JP2022514786A5 - - Google Patents
Info
- Publication number
- JP2022514786A5 JP2022514786A5 JP2021536253A JP2021536253A JP2022514786A5 JP 2022514786 A5 JP2022514786 A5 JP 2022514786A5 JP 2021536253 A JP2021536253 A JP 2021536253A JP 2021536253 A JP2021536253 A JP 2021536253A JP 2022514786 A5 JP2022514786 A5 JP 2022514786A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- cdr2
- cdr1
- cdr3
- linker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024181493A JP2025026839A (ja) | 2018-12-21 | 2024-10-17 | Ｍｕｃ１８に特異的な抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018122572 | 2018-12-21 | ||
| CNPCT/CN2018/122572 | 2018-12-21 | ||
| PCT/US2019/067457 WO2020132232A2 (en) | 2018-12-21 | 2019-12-19 | Antibodies specific to muc18 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024181493A Division JP2025026839A (ja) | 2018-12-21 | 2024-10-17 | Ｍｕｃ１８に特異的な抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022514786A JP2022514786A (ja) | 2022-02-15 |
| JP2022514786A5 true JP2022514786A5 (https=) | 2022-12-16 |
| JP7578289B2 JP7578289B2 (ja) | 2024-11-06 |
Family
ID=71101906
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536253A Active JP7578289B2 (ja) | 2018-12-21 | 2019-12-19 | Ｍｕｃ１８に特異的な抗体 |
| JP2024181493A Pending JP2025026839A (ja) | 2018-12-21 | 2024-10-17 | Ｍｕｃ１８に特異的な抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024181493A Pending JP2025026839A (ja) | 2018-12-21 | 2024-10-17 | Ｍｕｃ１８に特異的な抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12364770B2 (https=) |
| EP (1) | EP3898964A4 (https=) |
| JP (2) | JP7578289B2 (https=) |
| CN (2) | CN117343187A (https=) |
| AU (2) | AU2019401657B2 (https=) |
| TW (2) | TWI855014B (https=) |
| WO (1) | WO2020132232A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020132190A1 (en) | 2018-12-21 | 2020-06-25 | Multitude Inc. | Antibodies specific to muc18 |
| EP4463135A2 (en) | 2022-01-10 | 2024-11-20 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2024081820A1 (en) | 2022-10-13 | 2024-04-18 | Sana Biotechnology, Inc. | Viral particles targeting hematopoietic stem cells |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| EP4716750A1 (en) | 2023-05-23 | 2026-04-01 | Sana Biotechnology, Inc. | Tandem fusogens and related lipid particles |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6824995B1 (en) * | 1998-03-03 | 2004-11-30 | Emory University | Diagnostic for metastatic prostate cancer |
| EP1470146B8 (en) * | 2001-12-28 | 2007-09-12 | Amgen Fremont Inc. | Antibodies against the muc18 antigen |
| JP2005516965A (ja) * | 2001-12-28 | 2005-06-09 | アブジェニックス・インコーポレーテッド | 抗ｍｕｃ１８抗体を使用する方法 |
| HUE026846T2 (en) * | 2007-12-18 | 2016-08-29 | Bioalliance Cv | Antibodies to Recognize Carbohydrate-Containing Epitope on CD43 and CEA Expressed on Cancer Cells and Procedures for their Use |
| CN102936283B (zh) * | 2008-01-31 | 2014-11-05 | 中国科学院生物物理研究所 | 抗人cd146的单克隆抗体，包含其的组合物，检测可溶性cd146的方法 |
| WO2010145895A1 (en) | 2009-05-14 | 2010-12-23 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compositions containing antibodies for treating cd5+ hla-dr+ b or t cell related diseases |
| TWI595007B (zh) * | 2012-09-10 | 2017-08-11 | Neotope Biosciences Ltd | 抗ｍｃａｍ抗體及相關使用方法 |
| ES2686692T3 (es) * | 2013-09-24 | 2018-10-19 | Oncoinvent As | Anticuerpo monoclonal anti CD146 |
| PT3116911T (pt) * | 2014-03-12 | 2019-09-04 | Prothena Biosciences Ltd | Anticorpos anti-mcam e métodos de utilização associados |
| CN104650231A (zh) * | 2015-02-13 | 2015-05-27 | 南京任诺药业有限公司 | 一种具备高效中和活性的人源化抗人cd146单克隆抗体 |
| EP3350226A2 (en) * | 2015-09-16 | 2018-07-25 | Prothena Biosciences Limited | Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis |
| WO2017149513A1 (en) * | 2016-03-03 | 2017-09-08 | Prothena Biosciences Limited | Anti-mcam antibodies and associated methods of use |
| US20190192573A1 (en) | 2016-08-19 | 2019-06-27 | Oncoinvent As | Anti-osteosarcoma car-t derived from the antibody oi-3 |
| WO2018220467A1 (en) | 2017-05-30 | 2018-12-06 | Foroogh Nejatollahi | Anti-muc18 human immunotoxin and applications thereof |
| CN108129567B (zh) | 2018-01-09 | 2019-02-26 | 南京任诺药业有限公司 | 一种具备高效中和活性的人源化抗人cd146单克隆抗体 |
| WO2020132190A1 (en) | 2018-12-21 | 2020-06-25 | Multitude Inc. | Antibodies specific to muc18 |
-
2019
- 2019-12-19 JP JP2021536253A patent/JP7578289B2/ja active Active
- 2019-12-19 WO PCT/US2019/067457 patent/WO2020132232A2/en not_active Ceased
- 2019-12-19 TW TW108146802A patent/TWI855014B/zh active
- 2019-12-19 TW TW113130223A patent/TW202519555A/zh unknown
- 2019-12-19 CN CN202311007127.1A patent/CN117343187A/zh active Pending
- 2019-12-19 CN CN201980092138.XA patent/CN113423830B/zh active Active
- 2019-12-19 AU AU2019401657A patent/AU2019401657B2/en active Active
- 2019-12-19 EP EP19900282.5A patent/EP3898964A4/en active Pending
-
2021
- 2021-06-17 US US17/351,014 patent/US12364770B2/en active Active
-
2024
- 2024-10-17 JP JP2024181493A patent/JP2025026839A/ja active Pending
-
2025
- 2025-06-16 US US19/239,203 patent/US20250367313A1/en active Pending
- 2025-12-22 AU AU2025283667A patent/AU2025283667A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022514786A5 (https=) | ||
| JP2025026839A5 (https=) | ||
| JP2022523710A5 (https=) | ||
| JP2021531825A5 (https=) | ||
| JP2021531826A5 (https=) | ||
| RU2487723C2 (ru) | Химерные и гуманизированные антитела к cd44, которые опосредствуют цитотоксичность в отношении раковых клеток | |
| JP2022506072A5 (https=) | ||
| JP2021525546A5 (https=) | ||
| JP2019511201A5 (https=) | ||
| JP2023511774A5 (https=) | ||
| JP2019536740A5 (https=) | ||
| TW201734037A (zh) | 多重專一性分子 | |
| JP2007526880A5 (https=) | ||
| JP2020503870A5 (https=) | ||
| JP2023547323A5 (https=) | ||
| JP2019505564A5 (https=) | ||
| JP2020530285A5 (https=) | ||
| JP2013506428A5 (https=) | ||
| JP2020534830A5 (https=) | ||
| JP2018503600A5 (https=) | ||
| JP2020534012A5 (https=) | ||
| JP2014515600A5 (https=) | ||
| JP2020524669A (ja) | 抗ｇｌｏｂｏ ｈ抗体を含有する抗体−薬物コンジュゲートおよびその使用 | |
| WO2022060832A1 (en) | Cd33 antibodies | |
| CN115397857A (zh) | 一种抗pd-l1和pd-l2抗体及其衍生物和用途 |